Exam 3 - Multiple Choice Flashcards
lyophilization is conducted at _____ to remove water by _____
a. high temp and high pressure; evaporation
b. high temp and high pressure; sublimation
c. low temp and low pressure; sublimation
d. low temp and low pressure; evaporation
c. low temp and low pressure; sublimation
what is an “allogeneic” cell transfer therapy?
a. cell therapies made with the patient’s own cells
b. a therapy wherein cell donor and recipient (patient) are the same
c. a therapy wherein cell donor and recipient (patient) are different
d. a therapy where cells can be infused independent of the type of disease
c. a therapy wherein cell donor and recipient (patient) are different
what is the drug tocilizumab used in CAR-T therapy for?
a. It stimulates CAR-T cells to more effectively kill cancer cells
b. It is used in lymphodepletion
c. To mitigate cytokine release syndrome
d. To help T cells expand and proliferate
c. To mitigate cytokine release syndrome
What is a largely unwanted by-product of lymphodepletion in patients prior to immune reconstitution in the context of CAR-T therapy?
a. Graft-versus-host disease and CAR-T rejection
b. Loss of absolute lymphocyte counts
c. Loss of regulatory T cells
d. Increased numbers of circulating T cells
b. Loss of absolute lymphocyte counts
Which of these is NOT a function or characteristic of the extracellular region of a chimeric antigen receptor?
a. It is made from an antibody fragment
b. It stimulates cells to divide and persist when infused
c. It directs the cell to recognize a specific cancer antigen
d. It binds to a cancer cell
b. It stimulates cells to divide and persist when infused
Most FDA-approved cell therapy products are for which indication:
a. Hematopoietic cell transplantation
b. Cell-based tissue regeneration
c. CAR-T therapy
d. Immunotherapy
a. Hematopoietic cell transplantation
(FDA-approved stem cell therapies in the US are for hematopoietic stem cell transplantation and FDA-approved cell-based therapy products are for blood cancers. These are the only stem cell therapies approved in the US as of now.)
Autologous cell-based therapies have a number of benefits compared to allogeneic therapies, but the disadvantage is that:
a. They can induce graft-versus-host disease
b. They are difficult to source in large numbers
c. They require higher dosages
d. They do not need to be regulated as drugs
b. They are difficult to source in large numbers
In the context of sourcing immune cells for adoptive transfer, what is one strategy that can potentially be employed to decrease the risk of graft-versus-host disease?
a. Engineer cells with chimeric antigen receptors
b. Do not use T cells from cancer patients
c. Source cells from more closely-matched donors
d. Irradiate cells prior to infusion
c. Source cells from more closely-matched donors
According to the graph concerning salmon calcitonin, which one of the following descriptions is correct
a. Salmon calcitonin is least stable at pH 3-4
b. The formulation ideal for drug stability is also most comfortable for patients when administered
c. Additives improve the stability of calcitonin
d. The rate of calcitonin degradation is pH-dependent
e. All of the above is correct
d. The rate of calcitonin degradation is pH-dependent
All of the following statements are true of monoclonal antibodies (mAbs) EXCEPT:
a. mAbs have light and heavy chains
b. mAbs are small proteins (~30,000 Da)
c. mAbs have beta sheet structures
d. mAbs have disulfide bonds
b. mAbs are small proteins (~30,000 Da)
A protein drug that consists of a monoclonal antibody linked to a potent, small molecule cytotoxin is called
a. A chimeric protein
b. An antibody-drug conjugate
c. A fusion protein
d. A PEGylated protein
b. An antibody-drug conjugate
In protein drug formulations, “preferential exclusion” refers to:
a. Excipients
b. A manufacturing process
c. Receptor binding
d. Syringes
a. Excipients
Which of the following components of a pre-filled syringe is most likely to increase the aggregation of a protein drug?
a. Luer lock
b. Needle cap
c. Syringe lubricant
d. Finger grip
c. Syringe lubricant
Common dosage forms for biologics include all of the following EXCEPT:
a. Solution for injection
b. Auto-injectors
c. Pre-filled syringe
d. Buccal patches
e. Lyophilized powder for reconstitution
d. Buccal patches
Which of the following is NOT the advantage of solution formulations of biologics as compared to other common dosage forms?
a. Simplest formulation
b. Least expensive to manufacture
c. Convenient for hospital personnel since they do not require reconstitution
d. Reduced rates of chemical and physical degradation
e. Can be inspected visually prior to administration
d. Reduced rates of chemical and physical degradation
Which of the following is NOT relevant to the stability of lyophilized protein products?
a. Lyophilization can cause protein instability by freeze-concentration
b. Lyoprotectants or cryoprotectants are used to inhibit perturbation of protein structure during lyophilization
c. Lyophilized products should be shaken to accelerate reconstitution
d. Once reconstituted, biologics are less stable than the lyophilized forms
e. Reconstituted solution of lyophilized proteins should be visually inspected for the presence of particles
c. Lyophilized products should be shaken to accelerate reconstitution
For drug activity to achieve systemic action via transdermal delivery, it must reach [A] ____________ layer in the skin, which [B] ____________.
a. [A] stratum corneum; [B] is a main barrier to permeation
b. [A] stratum corneum; [B] contains cells that get nutrition from other layers
c. [A] viable epidermis; [B] is a source of skin color and tanning
d. [A] dermis; [B] contains pain sensors and leaves scars if injured
e. [A] dermis; [B] consists of dead cells and lipid
d. [A] dermis; [B] contains pain sensors and leaves scars if injured
Which one of the following is LEAST relevant to transdermal delivery?
a. Drugs with a molecular weight < 1000 Da and high oil/water partition coefficients are suitable for transdermal delivery.
b. Hydrated skin is easier for a drug to penetrate than dry skin
c. Reducing agents such as ascorbate or dithiothreitol can enhance skin permeability by disrupting disulfide bonds of proteins in keratinized cells
d. Transdermal delivery is suitable for drugs with high dose requirement
e. Organic solvents such as azone or dimethyl sulfoxide increase the skin permeability by disrupting the ordered lipid bilayer structure of stratum corneum
d. Transdermal delivery is suitable for drugs with high dose requirement
The following products are applied on skin. However, one of them aims to have an effect on a different location (system vs. local) than others. Which one is it?
a. ALACORT – hydrocortisone cream
b. Benzo-Jel – anesthetic gel
c. Burt’s Bees Medicated Lip Balm – with beeswax, camphor, menthol, clove oil, anise, eucalyptus, spearmint and lemon balm
d. ADVANCED SKIN LIGHTENING SERUM – hydroquinone gel
e. Exelon rivastigmine patch
e. Exelon rivastigmine patch
Consider the FDA memorandum and the Blackbox warning of Xulane patch. Which of the following is desirable advice for a patient prescribed a transdermal patch?
a. Encourage the use of clear (transparent) patch to reduce patient’s resistance to medication
b. A transdermal patch may be cut into several pieces and placed on different parts of the body to increase the bioavailability of a drug
c. Within the recommended areas of application, patches may be applied rotating the area to avoid skin irritation
d. A transdermal patch may be substituted for oral dosage forms as long as they contain the same drug and the same dose
e. When a new patch is applied, the old patch may be left on the skin as long as it stays in order to maximize the bioavailability of a drug
c. Within the recommended areas of application, patches may be applied rotating the area to avoid skin irritation
Which one of the following is most difficult to deliver via transdermal patches
a. Human growth hormone
b. Estradiol
c. Fentanyl
d. Nitroglycerin
e. Scopolamine
a. Human growth hormone